Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Rasburicase	94
Overall Study	STARTED	Rasburicase + Allopurinol	93
Overall Study	STARTED	Allopurinol	93
Overall Study	Treated	Rasburicase	92
Overall Study	Treated	Rasburicase + Allopurinol	92
Overall Study	Treated	Allopurinol	91
Overall Study	COMPLETED	Rasburicase	90
Overall Study	COMPLETED	Rasburicase + Allopurinol	86
Overall Study	COMPLETED	Allopurinol	86
Overall Study	NOT COMPLETED	Rasburicase	4
Overall Study	NOT COMPLETED	Rasburicase + Allopurinol	7
Overall Study	NOT COMPLETED	Allopurinol	7

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00230178/flow